International Journal of Drug Policy
Volume 14, Issue 5 , Pages 381-387, December 2003

Injection drug users’ use of pharmacies for purchasing needles in Anchorage, Alaska

  • Dennis G Fisher

      Affiliations

    • Centre for Behavioural Research and Services, California State University Long Beach, 1090 Atlantic Avenue, Long Beach, CA 90813, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-562-495-2330; fax: +1-562-983-1421.
  • ,
  • Andrea M Fenaughty

      Affiliations

    • Alaska Department of Health and Social Services, Data and Evaluation Unit, 3601 C Street #760, Anchorage, AK 99508, USA
  • ,
  • Henry H Cagle

      Affiliations

    • Viral Hepatitis Program, Alaska Native Medical Centre, ANC-HEP, 4315 Diplomacy Drive, Anchorage, AK 99508, USA
  • ,
  • Grace L Reynolds

      Affiliations

    • Centre for Behavioural Research and Services, California State University Long Beach, 1090 Atlantic Avenue, Long Beach, CA 90813, USA

Received 1 December 2002; received in revised form 15 March 2003; accepted 21 July 2003.

Abstract 

Objectives: Sterile needle and syringe (NS) access may play a significant role in the reduction of disease transmission. This study describes various characteristics of injection drug users’ (IDUs) procurement of NS at pharmacies.

Methods: IDUs were recruited as part of a two-arm clinical trial with one arm being taught how to purchase NS at pharmacies and the other arm being able to exchange NS at a needle exchange. Data were analysed using descriptive statistics (chi-square and binomial tests for categorical data, t-tests, ANOVA, correlation and Wilcoxon rank sums for interval-level data) and run using SAS [SAS/STAT User’s Guide, Version 6, 4th ed., vols. 1 and 2, SAS Institute Inc., Cary, NC].

Results: IDUs were able to purchase NS at most Anchorage pharmacies. More IDUs randomised to a syringe exchange programme (SEP) arm of a clinical trial obtained NS from known sterile sources as compared to those IDUs randomised to the pharmacy sales arm.

Conclusions: Communities seeking to maximise the proportion of IDUs who obtain sterile NS need to have both legal pharmacy sales and SEPs.

Keywords:  Needle exchange, Pharmacy sales, Clinical trial

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(03)00138-5

doi:10.1016/S0955-3959(03)00138-5

International Journal of Drug Policy
Volume 14, Issue 5 , Pages 381-387, December 2003